VOYA Investment Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-17,076
| Closed | -$38.9K | – | 2854 |
|
|
2024
Q2 | $38.9K | Buy |
+17,076
| New | +$65.2K | ﹤0.01% | 2808 |
|
|
2022
Q2 | – | Sell |
-14,906
| Closed | -$113K | – | 2919 |
|
|
2022
Q1 | $113K | Sell |
14,906
-153
| -1% | -$1.45K | ﹤0.01% | 2496 |
|
|
2021
Q4 | $154K | Sell |
15,059
-112,728
| -88% | -$1.44M | ﹤0.01% | 2587 |
|
|
2021
Q3 | $1.72M | Sell |
127,787
-9,571
| -7% | -$156K | ﹤0.01% | 1253 |
|
|
2021
Q2 | $3.01M | Sell |
137,358
-34,655
| -20% | -$770K | 0.01% | 1032 |
|
|
2021
Q1 | $4.14M | Sell |
172,013
-59,568
| -26% | -$1.38M | 0.01% | 911 |
|
|
2020
Q4 | $4.17M | Sell |
231,581
-18,829
| -8% | -$281K | 0.01% | 869 |
|
|
2020
Q3 | $2.89M | Buy |
250,410
+66,346
| +36% | +$1.1M | 0.01% | 899 |
|
|
2020
Q2 | $4.46M | Sell |
184,064
-23,702
| -11% | -$392K | 0.01% | 786 |
|
|
2020
Q1 | $2.29M | Buy |
207,766
+94,480
| +83% | +$1.76M | 0.01% | 905 |
|
|
2019
Q4 | $2.99M | Sell |
113,286
-78,147
| -41% | -$1.83M | 0.01% | 957 |
|
|
2019
Q3 | $4.36M | Sell |
191,433
-119,512
| -38% | -$3.77M | 0.01% | 834 |
|
|
2019
Q2 | $9.53M | Sell |
310,945
-172,614
| -36% | -$3.63M | 0.02% | 630 |
|
|
2019
Q1 | $8.03M | Buy |
483,559
+240,942
| +99% | +$4.57M | 0.02% | 653 |
|
|
2018
Q4 | $4.65M | Sell |
242,617
-111,039
| -31% | -$4.16M | 0.01% | 779 |
|
|
2018
Q3 | $18.5M | Sell |
353,656
-96,178
| -21% | -$5.24M | 0.04% | 453 |
|
|
2018
Q2 | $19.6M | Buy |
449,834
+444,204
| +7,890% | +$19M | 0.04% | 445 |
|
|
2018
Q1 | $209K | Buy |
+5,630
| New | +$150K | ﹤0.01% | 2294 |
|
VOYA Investment Management's GTHX Position: Q3 2024 in Review
VOYA Investment Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 17,076 shares — an estimated $38.9K sold.
VOYA Investment Management first reported a position in GTHX in Q1 2018 and held it in 18 quarters. The position peaked at $19.6M in Q2 2018. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- VOYA Investment Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- VOYA Investment Management sold 17,076 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $38.9K.
- VOYA Investment Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 18 quarters.
- VOYA Investment Management's G1 Therapeutics, Inc. Common Stock position peaked at $19.6M in Q2 2018.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.
Based on VOYA Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.